Cognizant Other Income (Expense) decreased by 4.0% to $24.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.3%, from $19.00M to $24.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 348.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | $2.00M | $5.00M | $5.00M | $1.00M | $14.00M | $28.00M | $36.00M | $10.00M | $27.00M | $25.00M | $27.00M | $20.00M | $10.00M | $19.00M | $25.00M | $21.00M | $25.00M | $24.00M |
| QoQ Change | — | +200.0% | +150.0% | +0.0% | -80.0% | >999% | +100.0% | +28.6% | -72.2% | +170.0% | -7.4% | +8.0% | -25.9% | -50.0% | +90.0% | +31.6% | -16.0% | +19.0% | -4.0% |
| YoY Change | — | — | — | — | +150.0% | +600.0% | +460.0% | +620.0% | +900.0% | +92.9% | -10.7% | -25.0% | +100.0% | -63.0% | -29.6% | +25.0% | +110.0% | — | +26.3% |